SCHEDULE: Dauntless Investment Group Discloses 8.4% Stake in Kazia

Dauntless Investment Group, LLC has disclosed a passive 8.4% ownership stake in Kazia Therapeutics Ltd, holding 115,769 American Depository Shares.

Summary

• Dauntless Investment Group, LLC reported beneficial ownership of 115,769 American Depository Shares (ADS) of Kazia Therapeutics Ltd.
• This ownership represents 8.4% of Kazia Therapeutics Ltd.'s class of securities.
• Dauntless Investment Group, LLC holds sole dispositive power over all 115,769 shares.
• The filing is an Amendment No. 1 to a previous Schedule 13G, indicating an update to a prior disclosure.
• Dauntless Investment Group, LLC is classified as a Single Family Office/Passive Investor and certifies that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant passive investment by Dauntless Investment Group, LLC in Kazia Therapeutics, suggesting confidence in the company's value. However, as a passive stake, it does not imply active engagement or influence on company operations, limiting its direct impact on operational sentiment.

Positives

• A significant institutional investor, Dauntless Investment Group, LLC, has taken an 8.4% passive stake in Kazia Therapeutics Ltd., potentially signaling confidence in the company's long-term prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased institutional ownership may be viewed positively, potentially signaling confidence in the company's valuation or future prospects.

Key Dates

Keywords

Kazia Therapeutics, Dauntless Investment Group, Schedule 13G, SEC filing, American Depository Shares, ADS, beneficial ownership, passive investment